ONCOLINES

Serial Number 79355700
Registration 7301525
700

Registration Progress

Application Filed
Oct 7, 2022
Under Examination
Approved for Publication
Nov 28, 2023
Published for Opposition
Nov 28, 2023
Registered
Feb 13, 2024

Trademark Image

ONCOLINES

Basic Information

Serial Number
79355700
Registration Number
7301525
Filing Date
October 7, 2022
Registration Date
February 13, 2024
Published for Opposition
November 28, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 13, 2024
Registration
Registered
Classes
042

Rights Holder

Oncolines B.V.

26
Address
Kloosterstraat 9
NL-5349 AB Oss
NL

Ownership History

Oncolines B.V.

Original Applicant
26
NL

Oncolines B.V.

Owner at Publication
26
NL

Oncolines B.V.

Original Registrant
26
NL

Legal Representation

Attorney
E. Anthony Figg

USPTO Deadlines

Next Deadline
1489 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20240213)
Due Date
February 13, 2030
Grace Period Ends
August 13, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Jun 11, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
May 15, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
May 15, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
May 13, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Feb 13, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 13, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 28, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 28, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 27, 2023 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Nov 8, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Nov 8, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Nov 8, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 24, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 30, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 29, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 29, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 25, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Sep 5, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Sep 5, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Aug 16, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Aug 15, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 24, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 24, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 20, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 17, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 042
Scientific research for medical purposes in the area of cancerous diseases; providing laboratory research in the field of gene expression, namely, cancer biology; medical research services, namely, performing proliferation assays in vitro with cell ines; scientific research services relating to testing of substances, drugs and pharmaceutical preparations in vitro with cell lines for scientific research purposes; scientific research services, namely, performing protein kinase assays; scientific research services relating to testing of substances, drugs and pharmaceutical preparations in protein kinase assays for scientific research purposes; scientific research services, namely, performing enzyme assays; consultancy relating to research and development in the field of medicines and pharmaceutical preparations

Classification

International Classes
042